Status:

COMPLETED

Determining the Minimal Amount of Exercise to Improve Glycaemic Control

Lead Sponsor:

Lancaster University

Conditions:

Type 2 Diabetes

Eligibility:

MALE

18-80 years

Phase:

NA

Brief Summary

In 2015, there were 415 million adults worldwide with type II diabetes and by 2040, typeII diabetes will affect one in ten adults worldwide. Type II diabetes reduces quality of life and total lifespan...

Detailed Description

Background Information and rationale Overarching aim: The purpose of this study is to identify the minimum number of calories that must be expended to improve the control of blood glucose in young and...

Eligibility Criteria

Inclusion

  • Cohort 1: 9 patients with type II diabetes under the following criteria:
  • Inclusion criteria
  • Aged 18 years and upwards
  • Capacity to consent to participation
  • Diagnosis of type II diabetes
  • BMI \>25
  • Exclusion criteria
  • Patient is aged under 18 years
  • Patient lacks capacity to consent to participation
  • Anything that investigators feel affects the study measurements or safety
  • Cohort 2: 9 young control subjects under the following criteria:
  • Inclusion criteria
  • Aged 18 - 40
  • Capacity to consent to participation
  • BMI \>25
  • Exclusion criteria
  • Subject is aged under 18 years
  • Subject lacks capacity to consent to participation
  • Subject on medication that affects glycaemic control
  • Anything that investigators feel affects the study measurements or safety
  • Cohort 3: 9 older control subjects under the following criteria:
  • Inclusion criteria
  • Aged \>60
  • Capacity to consent to participation
  • BMI \>25
  • Exclusion criteria
  • Subject is aged under 18 years
  • Subject lacks capacity to consent to participation
  • Subject on medication that affects glycaemic control
  • Anything that investigators feel affects the study measurements or safety

Exclusion

    Key Trial Info

    Start Date :

    October 1 2019

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    September 29 2022

    Estimated Enrollment :

    21 Patients enrolled

    Trial Details

    Trial ID

    NCT04129268

    Start Date

    October 1 2019

    End Date

    September 29 2022

    Last Update

    May 22 2023

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Royal Lancaster Infirmary

    Lancaster, United Kingdom